Cargando…

Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease

Peroxisome proliferator-activated receptors (PPARs) are a group of ligand-binding transcription factors with pivotal action in regulating pleiotropic signaling pathways of energetic metabolism, immune responses and cell proliferation and differentiation. A significant body of evidence indicates that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuior, Elena Valeria, Zvintzou, Evangelia, Filippatos, Theodosios, Giannatou, Katerina, Mparnia, Victoria, Simionescu, Maya, Gafencu, Anca Violeta, Kypreos, Kyriakos E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604751/ https://www.ncbi.nlm.nih.gov/pubmed/37893070 http://dx.doi.org/10.3390/biomedicines11102696

Ejemplares similares

High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities
por: Zvintzou, Evangelia, et al.
Publicado: (2023)

Differential action of glucocorticoids on apolipoprotein E gene expression in macrophages and hepatocytes
por: Trusca, Violeta Georgeta, et al.
Publicado: (2017)

The Opposite Effect of c-Jun Transcription Factor on Apolipoprotein E Gene Regulation in Hepatocytes and Macrophages
por: Trusca, Violeta G., et al.
Publicado: (2019)

Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
por: Makris, Anastasios, et al.
Publicado: (2023)

Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond
por: Fuior, Elena V., et al.
Publicado: (2019)

Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells
por: Brehar, Felix Mircea, et al.
Publicado: (2017)

Apolipoprotein A-II, a Player in Multiple Processes and Diseases
por: Florea, Gabriela, et al.
Publicado: (2022)

Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception
por: E. Kypreos, Kyriakos, et al.
Publicado: (2018)

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
por: Kersten, Sander
Publicado: (2008)

Adenovirus-Mediated FasL Minigene Transfer Endows Transduced Cells with Killer Potential
por: Dumitrescu, Madalina, et al.
Publicado: (2020)

The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-κB Activation
por: Trusca, Violeta G., et al.
Publicado: (2019)

Medicines for Obesity: Appraisal of Clinical Studies with Grading of Recommendations, Assessment, Development, and Evaluation Tool
por: Karavia, Eleni A., et al.
Publicado: (2023)

Enhanced Suppression of Immune Cells In Vitro by MSC Overexpressing FasL
por: Vacaru, Ana-Maria, et al.
Publicado: (2020)

High-density lipoprotein cholesterol and multiple myeloma: A systematic review and meta-analysis
por: Makris, Anastasios, et al.
Publicado: (2023)

Functional Role of VCAM-1 Targeted Flavonoid-Loaded Lipid Nanoemulsions in Reducing Endothelium Inflammation
por: Fuior, Elena Valeria, et al.
Publicado: (2019)

Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features
por: Tudorache, Irina Florina, et al.
Publicado: (2017)

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges
por: Lazaris, Vasileios, et al.
Publicado: (2021)

Evaluation of VCAM-1 Targeted Naringenin/Indocyanine Green-Loaded Lipid Nanoemulsions as Theranostic Nanoplatforms in Inflammation
por: Fuior, Elena Valeria, et al.
Publicado: (2020)

Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe (−/−) mice with hyperhomocysteinemia
por: Li, Hongjun, et al.
Publicado: (2016)

Peroxisome Proliferators: Response
por: Melnick, R
Publicado: (2001)

Perplexing peroxisome proliferators.
por: Citron, M
Publicado: (1995)

Increased miR-142 Levels in Plasma and Atherosclerotic Plaques from Peripheral Artery Disease Patients with Post-Surgery Cardiovascular Events
por: Barbalata, Teodora, et al.
Publicado: (2020)

A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination
por: Filippatos, Theodosios D.
Publicado: (2012)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor
por: Huang, Z, et al.
Publicado: (2008)

Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells
por: Constantinescu, Cristina Ana, et al.
Publicado: (2019)

STAT1 Interacts with RXRα to Upregulate ApoCII Gene Expression in Macrophages
por: Trusca, Violeta G., et al.
Publicado: (2012)

Serum lipoprotein (a) and atherosclerotic changes in hemodialysis patients
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2013)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

K2 Transfection System Boosts the Adenoviral Transduction of Murine Mesenchymal Stromal Cells
por: Dumitrescu, Madalina, et al.
Publicado: (2021)

Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
por: Youssef, Jihan, et al.
Publicado: (2002)

Nano-Polyplexes Mediated Transfection of Runx2-shRNA Mitigates the Osteodifferentiation of Human Valvular Interstitial Cells
por: Voicu, Geanina, et al.
Publicado: (2020)

Pmp27 promotes peroxisomal proliferation
Publicado: (1995)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
por: Nishida, K., et al.
Publicado: (2008)

Phthalate esters as peroxisome proliferator carcinogens.
por: Warren, J R, et al.
Publicado: (1982)

An overview of peroxisome proliferator-induced hepatocarcinogenesis.
por: Rao, M S, et al.
Publicado: (1991)

High-Density Lipoprotein Nanoparticle Imaging in Atherosclerotic Vascular Disease
por: Leeper, Nicholas J., et al.
Publicado: (2017)

Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
por: Reiner, Željko
Publicado: (2018)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7enf3k5vlt6km71p529nhf9m02